Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IIID MelanomaLast Updated:February 21, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IIID MelanomaLast Updated:February 21, 2024Not yet recruiting
Condition(s):MelanomaLast Updated:October 29, 2021Recruiting
Condition(s):Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7Last Updated:November 9, 2023Recruiting
Condition(s):Clinical Stage IV Cutaneous Melanoma AJCC v8; IL13RA2 Positive; Metastatic Melanoma; Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV; Melanoma; Uveal Melanoma; Acral Melanoma; Neuroendocrine Tumors; Paraganglioma; Adrenocortical Carcinoma; Pancreatic Neuroendocrine Tumor; Thyroid Cancer; Breast Cancer; Lung Adenocarcinoma; Head and Neck Squamous Cell CarcinomaLast Updated:March 22, 2024Recruiting
Condition(s):Anatomic Stage IV Breast Cancer AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Hormone Receptor-Positive Breast Carcinoma; Locally Advanced Cutaneous Melanoma; Metastatic Acral Lentiginous Melanoma; Metastatic Conjunctival Melanoma; Metastatic Cutaneous Melanoma; Metastatic HER2-Negative Breast Carcinoma; Metastatic Mucosal Melanoma; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Acral Lentiginous Melanoma; Recurrent Cutaneous Melanoma; Recurrent Mucosal Melanoma; Refractory HER2-Negative Breast Carcinoma; Unresectable Acral Lentiginous Melanoma; Unresectable Cutaneous Melanoma; Unresectable Mucosal MelanomaLast Updated:January 25, 2024Recruiting
Condition(s):Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV; Stage III Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma; Unresectable MelanomaLast Updated:June 28, 2022Recruiting
Condition(s):Melanoma Stage III; Melanoma Stage IV; MelanomaLast Updated:June 1, 2022Recruiting
Condition(s):Melanoma (Skin); Skin Cancer; Skin Melanoma; Skin CarcinomaLast Updated:March 22, 2024Recruiting
Condition(s):Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Melanoma; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Unresectable MelanomaLast Updated:February 28, 2024Recruiting
Condition(s):Clinical Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8Last Updated:July 24, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.